0001626370-24-000003.txt : 20240412 0001626370-24-000003.hdr.sgml : 20240412 20240412115415 ACCESSION NUMBER: 0001626370-24-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 EFFECTIVENESS DATE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inomagen Therapeutics, Inc. CENTRAL INDEX KEY: 0001626370 ORGANIZATION NAME: IRS NUMBER: 472024034 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-510456 FILM NUMBER: 24840515 BUSINESS ADDRESS: STREET 1: 21 EAST HURON ST., #807 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-961-8166 MAIL ADDRESS: STREET 1: 21 EAST HURON ST., #807 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Rhythm Therapeutics, Inc. DATE OF NAME CHANGE: 20141124 D 1 primary_doc.xml X0708 D LIVE 0001626370 Inomagen Therapeutics, Inc. 1375 W Fulton Street CHICAGO IL ILLINOIS 60607 312-961-8166 DELAWARE Rhythm Therapeutics, Inc. Corporation true Rishi Arora 1375 W Fulton Street Chicago IL ILLINOIS 60607 Executive Officer Director James R. Vogler 1375 W Fulton Street Chicago IL ILLINOIS 60607 Director Marc Penn 1375 W Fulton Street Chicago IL ILLINOIS 60607 Director Biotechnology Decline to Disclose 06b false 2024-03-29 false true true true false 0 6626079 200000 6426079 A portion of the Total Offering Amount is comprised of the cancellation of indebtedness through the conversion of one or more outstanding promissory notes previously issued by the Company. false 4 0 0 0 false Inomagen Therapeutics, Inc. /s/ Rishi Arora, MD Rishi Arora, MD President 2024-04-12